This article analyzes the use of supercritical CO2green technology in the reactive crystallization processes involved in the formation of a bioMOF that contains curcumin and ZnIImetal centers. A new phase with a [Zn(curcumin)]ncomposition, termed sc-CCMOF-1, is presented. The developed scCO2protocol allows high yields of the small-sized crystalline material, which was characterized by the use of the recently developed electron diffraction tomography method applied to the resolution of submicrometric crystals. A remarkable 3D macrostructure with a complex morphology was obtained. To analyze the crystallization mechanism, multiple identical runs were performed under similar experimental conditions to study in each time period the crystal growth progress ex situ by X-ray diffraction and scanning electron microscopy. These experiments indicated that the process to achieve the sc-CCMOF-1 in a crystalline form involves the formation of amorphous or semicrystalline metastable phases that derived into hierarchical stable and crystalline nanoflower aggregates. In addition, a potential therapeutic application of the bioMOF has been tested by studying the released of the curcumin molecule at neutral pH.
Crystalline Curcumin bioMOF obtained by precipitation in supercritical CO2and structural determination by Electron Diffraction Tomography
Mugnaioli, Enrico;
2018-01-01
Abstract
This article analyzes the use of supercritical CO2green technology in the reactive crystallization processes involved in the formation of a bioMOF that contains curcumin and ZnIImetal centers. A new phase with a [Zn(curcumin)]ncomposition, termed sc-CCMOF-1, is presented. The developed scCO2protocol allows high yields of the small-sized crystalline material, which was characterized by the use of the recently developed electron diffraction tomography method applied to the resolution of submicrometric crystals. A remarkable 3D macrostructure with a complex morphology was obtained. To analyze the crystallization mechanism, multiple identical runs were performed under similar experimental conditions to study in each time period the crystal growth progress ex situ by X-ray diffraction and scanning electron microscopy. These experiments indicated that the process to achieve the sc-CCMOF-1 in a crystalline form involves the formation of amorphous or semicrystalline metastable phases that derived into hierarchical stable and crystalline nanoflower aggregates. In addition, a potential therapeutic application of the bioMOF has been tested by studying the released of the curcumin molecule at neutral pH.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.